Your browser doesn't support javascript.
loading
Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations.
Delgado Martínez, Carolina; Gómez-Rubio, Mariano; Gómez-Domínguez, Cecilia.
Afiliación
  • Delgado Martínez C; Division of Digestive Diseases, Hospital Universitario de Getafe, Madrid, Spain. Electronic address: cdelgadom91@gmail.com.
  • Gómez-Rubio M; Division of Digestive Diseases, Hospital Universitario de Getafe, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain. Electronic address: mgomezrubio@salud.madrid.org.
  • Gómez-Domínguez C; Division of Digestive Diseases, Hospital Universitario de Getafe, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain. Electronic address: ceciliagd95@hotmail.com.
Ann Hepatol ; 21: 100225, 2021.
Article en En | MEDLINE | ID: mdl-32687878

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C / Carcinoma Hepatocelular / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C / Carcinoma Hepatocelular / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article